AzTrials
AzTrials

Pelvic Floor DysfunctionNCT03511911

The Evaluation of Pelvic Floor Muscle Function: A Reliability and Correlation Study

A study testing evaluation of pelvic floor muscle function through the PHENIX instrument and vaginal palpation in people with Pelvic Floor Dysfunction, run by Peking Union Medical College Hospital at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

1. To explore the correlations among measures of PFM strength between using vaginal palpation quantified by modified Oxford Grading Scale and Levator ani testing and manometry in PHENIX instrument; 2. To determine the intra- and inter-rater reliability of PFM strength measured using manometry in PHENIX instrument. Read more about this study

Who is it for?
Ages 18 to 80 years, women onlyHealthy volunteers can take part
Conditions the study is for
Pelvic Floor Dysfunction
What is being tested?
evaluation of pelvic floor muscle function through the PHENIX instrument and vaginal palpation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
450 participants
Where
1 siteChina
Study dates
11 Jun 2018to 31 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Having sex life and tolerable to vaginal examination
  • Planning to live locally for a long time
  • Volunteers are divided into three groups Group A: healthy women
  • healthy women for physical examination
  • except in the first year after delivery,duration of lactation or with a clear diagnosis as pelvic organ prolapse beyond the level of hymen or incontinence.
  • Group B:patients with pelvic floor disorders
Show all 10Show fewer
  • patients diagnosed as incontinence by clinical presentation(patients with urinary incontinence are required to complete the questionnaire of ICIQ-SF)
  • patients with pelvic organ prolapse beyond the level of hymen
  • except in the first year after delivery,duration of lactation and patients with chronic pelvic pain
  • Group C: female who give birth to a child within a year(compliance and twice assessment are guaranteed,but PFMT are not allowed during the interval)

Who cannot join

  • Patients who are undergoing pelvic floor muscle training
  • History of radical operation of pelvic cavity(cervical cancer,rectal cancer,bladder cancer, ect)
  • History of pelvic radiotherapy
  • History of pelvic floor surgery
  • Duration of pregnancy
  • Latex allergy
  • Colpitis
  • Operation on pelvis within 6 months

Trial locations and contacts

1 site in 1 country.

Zhijing Sun, MD contact

13651314354

sunzhj2001@sina.com

China1 site, 1 recruiting
  • Peking Union Medical College Hospital, Chinese Academy of Medicine Sciences

    Beijing, Beiing, 100730

    Zhijing Sun, MD, 13651314354, sunzhj2001@sina.com

    Recruiting

Other trials in China

About this study

  1. To explore the correlations among measures of PFM strength between using vaginal palpation quantified by modified Oxford Grading Scale and Levator ani testing and manometry in PHENIX instrument;
  2. To determine the intra- and inter-rater reliability of PFM strength measured using manometry in PHENIX instrument.
Read the detailed description

This is a study using a randomized crossover blind method.All the volunteers are divided into 2 groups randomly. At the first time, a gynecological physician evaluates patient's pelvic floor muscle strength by vaginal palpation based on modified Oxford Grading Scale(MOS) and Levator ani testing(LAT) without telling patient her result, and record it on a unique paper other than in the Case Report Form.

At the same day, patient will be tested by inspector A or B randomly twice with the PHENIX instrument.A 5 minutes' interval is needed between two tests in order to reduce the possibility of fatigue of pelvic floor muscles. The outcome is secretive to the patient as well.

A second time evaluation is required in 3 days' later by a different inspector from the first time.(interrater and intrarater) All the data including strength of MOS and LAT, the outcomes by inspector A and B, cannot be collected together and told to the patient until she finished the whole process.

Pelvic floor muscle training is not permitted during the evaluations.

Being tested
evaluation of pelvic floor muscle function through the PHENIX instrument, vaginal palpation
Keywords
Pelvic floor muscle strength, modified Oxford Grading Scale, Levator ani testing, vaginal contraction pressure, reliability

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • evaluation of pelvic floor muscle function through the PHENIX instrumentDiagnostic test

    the PHENIX instrument was designed and produced for sensing muscle activity with surface electrodes, pressure probes and external captors,so it could test biological signals of pelvic floor muscle in human body.

  • vaginal palpationDiagnostic test

    vaginal palpation is based on modified Oxford Grading Scale(MOS) and Levator ani testing(LAT) to test patients' pelvic muscle strength

Study groups in NCT03511911
Study groupRoleWhat they receive
GROUP A1ExperimentalIn GROUP A1, participants are all healthy women.A gynecological physician evaluates the participant's pelvic floor muscle strength by vaginal palpation based on modified Oxford Grading Scale(MOS) and Levator ani testing(LAT) without telling the participant her result, and records it on a unique paper other than in the Case Report Form.Then inspector A will test them twice using the PHENIX instrument with a 5 minutes' interval at the same day.After three days,participants in group A1 will be tested by inspector B twice in the same way as what they have done the first day.
Receives: Diagnostic Test: evaluation of pelvic floor muscle function through the PHENIX instrument; Diagnostic Test: vaginal palpation
GROUP A2ExperimentalIn GROUP A2,participants are all healthy women.A gynecological physician evaluates participant's pelvic floor muscle strength by vaginal palpation without telling the participant her result, and records it on a unique paper other than in the Case Report Form as what GROUP A1 do.Then it is inspector B who will test them twice using the PHENIX instrument with a 5 minutes' interval at the same day.Three days later,participants in group A2 will be tested by inspector A twice in the same way as what they have done the first day.
Receives: Diagnostic Test: evaluation of pelvic floor muscle function through the PHENIX instrument; Diagnostic Test: vaginal palpation
GROUP B1ExperimentalIn GROUP B1,patients are all with pelvic floor disorders.A gynecological physician evaluates the patient's pelvic floor muscle strength by vaginal palpation based on modified Oxford Grading Scale(MOS) and Levator ani testing(LAT) without telling the patient her result, and records it on a unique paper other than in the Case Report Form.Then inspector A will test them twice using the PHENIX instrument with a 5 minutes' interval at the same day.After three days,patients in group B1 will be tested by inspector B twice in the same way as what they have done the first day.
Receives: Diagnostic Test: evaluation of pelvic floor muscle function through the PHENIX instrument; Diagnostic Test: vaginal palpation
GROUP B2ExperimentalIn GROUP B2,patients are all with pelvic floor disorders.A gynecological physician evaluates the patient's pelvic floor muscle strength by vaginal palpation without telling patient her result, and records it on a unique paper other than in the Case Report Form as what GROUP B1 do.Then it is inspector B who will test them twice using the PHENIX instrument with a 5 minutes' interval at the same day.Three days later,patients in group B2 will be tested by inspector A twice in the same way as what they have done the first day.
Receives: Diagnostic Test: evaluation of pelvic floor muscle function through the PHENIX instrument; Diagnostic Test: vaginal palpation
GROUP C1ExperimentalIn GROUP C1,participants are all female who give birth to a child within a year(compliance and twice assessment are guaranteed,but PFMT are not allowed during the interval).A gynecological physician evaluates the participant's pelvic floor muscle strength by vaginal palpation based on modified Oxford Grading Scale(MOS) and Levator ani testing(LAT) without telling the participant her result, and records it on a unique paper other than in the Case Report Form.Then inspector A will test them twice using the PHENIX instrument with a 5 minutes' interval at the same day.After three days,participants in group C1 will be tested by inspector B twice in the same way as what they have done the first day.
Receives: Diagnostic Test: evaluation of pelvic floor muscle function through the PHENIX instrument; Diagnostic Test: vaginal palpation
GROUP C2ExperimentalIn GROUP C2,participants are all female who give birth to a child within a year(compliance and twice assessment are guaranteed,but PFMT are not allowed during the interval).A gynecological physician evaluates the participant's pelvic floor muscle strength by vaginal palpation without telling patient her result, and records it on a unique paper other than in the Case Report Form as what GROUP C1 do.Then it is inspector B who will test them twice using the PHENIX instrument with a 5 minutes' interval at the same day.Three days later,participants in group C2 will be tested by inspector A twice in the same way as what they have done the first day.
Receives: Diagnostic Test: evaluation of pelvic floor muscle function through the PHENIX instrument; Diagnostic Test: vaginal palpation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximum vaginal contraction pressure

    Maximum vaginal contraction pressure is evaluated by manometry

    Measured: 3 days

Secondary outcomes (5)
  1. vaginal rest pressure

    measure when no vaginal contraction by manometry

    Measured: 3 days

  2. Pelvic floor muscle strength

    The modified Oxford Grading Scale is used to quantify PFM strength through vaginal palpation

    Measured: 1 day

  3. Pelvic floor muscle strength(repitition)

    Levator ani testing is used to quantify PFM strength

    Measured: 1 day

  4. Pelvic floor muscle contraction endurance

    muscle contractions maintained for 0 s are defined as grade 0,and 5 s or longer as grade V. Normal muscles can maintain the contraction for 5 s. The endurance is measured by PHENIX instrument.

    Measured: 3 days

  5. pelvic organ prolapse quantification(POP-Q)

    POP-Q is measured when maximum valsalva

    Measured: 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Apr 2018
  2. Study start11 Jun 2018
  3. Primary completion31 Dec 2020 (estimated)
  4. Study completion31 Dec 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
450 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03511911
Sponsor's protocol ID
JS-1548
Status last verified
Apr 2018
First submitted
13 Apr 2018
Last updated
12 Sep 2018
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing evaluation of pelvic floor muscle function through the PHENIX instrument and vaginal palpation in people with Pelvic Floor Dysfunction, run by Peking Union Medical College Hospital at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Zhijing Sun, MD (13651314354, sunzhj2001@sina.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximum vaginal contraction pressure (time frame: 3 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Sep 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in